Table 1 Patient characteristics according to presence or absence of arterial transit artifact
From: Arterial transit artifact as a short-term prognostic indicator in acute ischemic stroke
All patients (n = 98) | ATA present (n = 46) | ATA absent (n = 52) | P value | |
|---|---|---|---|---|
Age, y | 62.7 (13.1) | 62.7 (12.9) | 62.8 (13.3) | 0.966 |
Sex, male | 68 (69.4) | 31 (67.4) | 37 (71.2) | 0.687 |
History | ||||
Hypertension | 78 (79.6) | 38 (82.6) | 40 (76.9) | 0.486 |
Diabetes mellitus | 28 (28.6) | 19 (41.3) | 9 (17.3) | 0.009* |
Obesity | 13 (13.3) | 8 (17.4) | 5 (9.6) | 0.257 |
Smoking | 40 (40.8) | 21 (45.7) | 19 (36.5) | 0.360 |
Laboratory data | ||||
TG, mmol/L | 1.475 (1.19, 2.57) | 1.415 (1.15, 2.32) | 1.61 (1.205, 2.705) | 0.906 |
TC, mmol/L | 3.965 (3.25, 4.71) | 4.06 (3.27, 4.86) | 3.93 (3.17, 4.66) | 0.584 |
HDL-C, mmol/L | 0.985 (0.86, 1.18) | 1.02 (0.86, 1.20) | 0.965 (0.84, 1.15) | 0.424 |
LDL-C, mmol/L | 2.425 (1.92, 2.96) | 2.445 (2.01, 2.96) | 2.385 (1.835, 2.985) | 0.436 |
FBG, mmol/L | 5.12 (4.56, 5.9) | 5.395 (4.67, 6.83) | 4.87 (4.465, 5.655) | 0.029* |
HbA1c, % | 6 (5.6, 6.8) | 6.2 (5.7, 7.4) | 5.85 (5.6, 6.3) | 0.064 |
BUN, mmol/L | 5 (4.1, 6.3) | 4.95 (4.2, 5.5) | 5.2 (4.05, 6.6) | 0.380 |
UA, µmol/L | 316.1 (82.6) | 314.0 (83.73) | 317.97 (82.31) | 0.816 |
Cr, µmol/L | 72.5 (60, 82) | 69.5 (59, 84) | 73.5 (64, 81) | 0.669 |
HCY, mol/L | 10.9 (8.2, 13.6) | 10.6 (7.7, 15.5) | 11.25 (8.7, 13.3) | 0.836 |
NIHSS baseline | 3 (2, 4) | 3 (2, 4) | 2 (2, 3.5) | 0.163 |
Infarct volume, mL | 1.3 (0.6, 2.1) | 1.65 (0.1, 2.7) | 1 (0.5, 1.6) | < 0.001* |
TOAST subtype | < 0.001* | |||
LAA | 44 (44.9) | 35 (76.1) | 9 (17.3) | |
CE | 17 (17.3) | 5 (10.9) | 12 (23.1) | |
SVO | 37 (37.8) | 6 (13.0) | 31 (59.6) | |
In hospital treatment | 0.888 | |||
Single antiplatelet | 54 (55.1) | 25 (54.3) | 29 (55.8) | |
Dual antiplatelet | 44 (44.9) | 21 (45.7) | 23 (44.2) | |
Ipsilateral hemisphere | ||||
CBFPLD = 1.5 s, mL/(100 g‧min) | 36.39 (32.33, 40.48) | 36.39 (31.81, 40.48) | 36.03 (33.28, 40.45) | 0.458 |
CBFPLD = 2.5 s, mL/(100 g‧min) | 41.53 (4.63) | 41.96 (4.89) | 41.14 (4.40) | 0.384 |
CBF differenceipsi, mL/(100 g‧min) | 4.96 (3.52) | 5.40 (2.70) | 3.84 (3.34) | 0.013* |
Contralateral hemisphere | ||||
CBFPLD = 1.5 s, mL/(100 g‧min) | 36.71 (34.47, 40.28) | 36.58 (33.51, 41.61) | 37.27 (34.58, 39.82) | 0.749 |
CBFPLD = 2.5 s, mL/(100 g‧min) | 41.91 (39.44, 46.99) | 41.84 (38.71, 47.13) | 42.02 (39.68, 46.33) | 0.918 |
CBF differencecontra, mL/(100 g‧min) | 4.58 (3.14) | 5.36 (2.83) | 4.62 (4.02) | 0.301 |
mRS > 2 | 28 (28.6) | 9 (19.6) | 19 (36.5) | < 0.001* |